This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Ctxt Pty Limited. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Matthew Lloyd Dennis
Introduction
Matthew Lloyd Dennis is an accomplished inventor based in Parkville, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of STING (Stimulator of Interferon Genes). His work focuses on developing compounds that can potentially treat or prevent diseases through innovative mechanisms.
Latest Patents
Matthew holds a patent for "Compound modulators of STING." This patent discloses compounds of formula (I), which serve as modulators of STING. The patent also includes pharmaceutical compositions comprising these compounds and outlines methods for using them in the treatment or prevention of diseases that can be ameliorated by the modulation of STING. He has 1 patent to his name.
Career Highlights
Matthew is currently associated with Ctxt Pty Limited, where he continues to explore and develop his innovative ideas. His work at the company reflects his commitment to advancing medical science and improving patient outcomes through novel therapeutic approaches.
Collaborations
Matthew has collaborated with notable colleagues, including Benjamin Joseph Morrow and Jonathan Grant Hubert. These partnerships have likely contributed to the depth and breadth of his research and innovations.
Conclusion
Matthew Lloyd Dennis exemplifies the spirit of innovation in the pharmaceutical industry. His work on STING modulators showcases the potential for new treatments that can significantly impact healthcare.